Article
Commercial porcine reproductive and respiratory syndrome virus (PRRSV)-2 modified live virus vaccine against heterologous single and dual Korean PRRSV-1 and PRRSV-2 challenge.
The Veterinary record - 28 Apr 2018
Jeong Jiwoon, Kim Seeun, Park Changhoon, Park Kee Hwan, Kang Ikjae, Park Su-Jin, Chae Chanhee
Abstract excerpt
This study evaluated porcine reproductive and respiratory syndrome virus (PRRSV)-2 modified live virus (MLV) vaccine against heterologous single and dual challenge of Korean PRRSV-1 and PRRSV-2. Pigs were administered PRRSV-2 MLV vaccine intramuscularly at 21 days of age and inoculated intranasally with both genotypes at 56 days of age. Vaccination of pigs with PRRSV-2 MLV vaccine resulted in reduction of viral...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.